Provided by Tiger Trade Technology Pte. Ltd.

Nektar Therapeutics

68.66
-2.3100-3.25%
Post-market: 69.791.13+1.65%19:25 EDT
Volume:735.84K
Turnover:50.94M
Market Cap:1.97B
PE:-7.06
High:71.68
Open:71.05
Low:67.63
Close:70.97
52wk High:77.97
52wk Low:6.48
Shares:28.69M
Float Shares:26.24M
Volume Ratio:0.88
T/O Rate:2.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.7300
EPS(LYR):-8.6765
ROE:-217.94%
ROA:-27.98%
PB:21.93
PE(LYR):-7.91

Loading ...

Earning Preview: Nektar Therapeutics this quarter’s revenue is expected to decrease by 65.16%, and institutional views are bullish

Earnings Agent
·
Mar 05

Nektar Therapeutics Publishes Presentation on Rezpegaldesleukin Treg Therapy for Atopic Dermatitis and Alopecia Areata

Reuters
·
Mar 04

BTIG Keeps Their Buy Rating on Nektar Therapeutics (NKTR)

TIPRANKS
·
Mar 02

Nektar Therapeutics Schedules Fourth-Quarter and Full-Year Financial Results Call

Reuters
·
Feb 27

Nektar Therapeutics to Present at TD Cowen Annual Health Care Conference

Reuters
·
Feb 25

A Look At Nektar Therapeutics (NKTR) Valuation After New UCSF Multiple Sclerosis Collaboration

Simply Wall St.
·
Feb 23

B. Riley Raises Price Target on Nektar Therapeutics to $150 From $105, Keeps Buy Rating

MT Newswires Live
·
Feb 23

Nektar Therapeutics Partners with UCSF to Study MS Antibody Therapy

Reuters
·
Feb 17

Nektar Therapeutics Announces Research Collaboration With Ucsf and DR. Stephen Hauser for Nktr-0165, a Tumor Necrosis Factor Receptor 2 (Tnfr2) Antibody, in Multiple Sclerosis

THOMSON REUTERS
·
Feb 17

Nektar Therapeutics Closes $460 Million Equity Offering

MT Newswires Live
·
Feb 14

BUZZ-U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National

Reuters
·
Feb 13

BUZZ-Nektar Therapeutics eases after boosted $400 mln share sale

Reuters
·
Feb 12

BRIEF-Nektar Therapeutics Announces Pricing Of Upsized $400 Million Public Offering

Reuters
·
Feb 12

Nektar Therapeutics - Shares Sold at $58.00 per Share

THOMSON REUTERS
·
Feb 12

BUZZ-Nektar extends surge after promising eczema drug data

Reuters
·
Feb 11

U.S. RESEARCH ROUNDUP-Coca-Cola, Rapid7, Walmart

Reuters
·
Feb 11

Nektar Therapeutics : Btig Raises Target Price to $151 From $118

THOMSON REUTERS
·
Feb 11

Nektar Therapeutics Launches $300 Million Public Offering with Pre-Funded Warrants

Reuters
·
Feb 11

Nektar Therapeutics Announces Proposed Public Offering

THOMSON REUTERS
·
Feb 11

Nektar Therapeutics - Announces $300 Mln Public Offering

THOMSON REUTERS
·
Feb 11